CUSIP 87164F105COMSNDXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
227 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 8.24M | $173.10M | −386.2K | Reduced |
| 2 | Kynam Capital Management, LP | 8.05M | $169.15M | −469.0K | Reduced |
| 3 | Vanguard Group Inc | 6.23M | $130.90M | +1.09M | Added |
| 4 | Goldman Sachs Group Inc | 5.70M | $119.66M |
| +208.9K |
| Added |
| 5 | Point72 Asset Management, L.P. | 4.88M | $102.57M | +627.0K | Added |
| 6 | Bank Of America Corp /De/ | 4.71M | $98.97M | +1.01M | Added |
| 7 | State Street Corp | 4.60M | $96.57M | +743.0K | Added |
| 8 | Eversept Partners, LP | 3.31M | $69.64M | −152.9K | Reduced |
| 9 | Franklin Resources Inc | 2.42M | $50.88M | +31.1K | Added |
| 10 | Kingdon Capital Management, L.L.C. | 2.35M | $49.37M | −150.0K | Reduced |
See every fund holding Syndax Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders